Literature DB >> 4905915

The sideroblastic anemias.

J D Hines, J A Grasso.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4905915

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  12 in total

1.  Serum pyridoxal in patients with gastric pathology.

Authors:  C R Sanderson; R E Davis
Journal:  Gut       Date:  1976-05       Impact factor: 23.059

2.  Primary acquired sideroblastic anaemia: response to treatment with pyridoxal-5-phosphate.

Authors:  D Y Mason; P M Emerson
Journal:  Br Med J       Date:  1973-02-17

3.  delta-Aminolevulinic acid synthetase in erythroblasts of patients with pyridoxine-responsive anemia. Hypercatabolism caused by the increased susceptibility to the controlling protease.

Authors:  Y Aoki; S Muranaka; K Nakabayashi; Y Ueda
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

4.  Alcohol and the blood.

Authors: 
Journal:  Br Med J       Date:  1978-06-10

5.  Idiopathic refractory sideroachrestic anemia (IRSA) progressing to acute mixed lymphoblastic-myelomonoblastic leukemia. Case report and review of the literature.

Authors:  R Hehlmann; B Zönnchen; E Thiel; B Walther
Journal:  Blut       Date:  1983-01

6.  The hypochromic anemias.

Authors:  M A Ali
Journal:  Can Fam Physician       Date:  1976-12       Impact factor: 3.275

7.  Iron granules in plasma cells.

Authors:  M K Cook; M Madden
Journal:  J Clin Pathol       Date:  1982-02       Impact factor: 3.411

8.  Sideroblastic anaemia. A review of seven paediatric cases.

Authors:  B C Hamel; E D Schretlen
Journal:  Eur J Pediatr       Date:  1982-03       Impact factor: 3.183

9.  [Alcohol-related disturbances in haematopoiesis (author's transl)].

Authors:  H D Waller; H C Benöhr
Journal:  Klin Wochenschr       Date:  1978-03-15

10.  Sideroblastic anaemia associated with lincomycin therapy.

Authors:  G Kokkini; E Tsianos; A Kappas
Journal:  Postgrad Med J       Date:  1983-12       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.